Skip to content
Quebec News Tribune – Lifestyle
Author:
Aravax
Aravax Awarded FDA Fast Track Designation for PVX108, a Next-Generation Immunotherapy for the Treatment of Peanut Allergy
August 3, 2026
Aravax Strengthens Board with Appointments of Carsten Hellmann and Andrew Oxtoby
April 8, 2026